FDA Drug Application (090631) for CARBIDOPA AND LEVODOPA by IMPAX LABS

Back to FDA Applications sponsored by IMPAX LABS

Application Number090631
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage10MG;100MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCARBIDOPA AND LEVODOPA
Active IngredientCARBIDOPA; LEVODOPA

Active IngredientCount
List of drugs with Active Ingredient CARBIDOPA16
List of drugs with Active Ingredient LEVODOPA17


Back to FDA Applications sponsored by IMPAX LABS